Holen Sie sich die Stockscreener-App
0.85
9.84%
-0.0928
Finanzdaten der Processa Pharmaceuticals Inc-Aktie (PCSA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Income/Loss |
13.77%
-2.8096
|
-2.4695 | -2.1676 | -2.7145 | -4.1055 |
| Income/Loss From Continuing Operations Before Tax |
13.37%
-2.7264
|
-2.4049 | -2.082 | -2.6126 | -4.0221 |
| Income/Loss From Continuing Operations After Tax |
13.37%
-2.7264
|
-2.4049 | -2.082 | -2.6126 | -4.0221 |
Net Income/Loss
|
13.37%
-2.7264
|
-2.4049 | -2.082 | -2.6126 | -4.0221 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
110.16%
2.4665
|
-24.27 | 27.00 | 26.94 | 22.77 |
| Diluted Average Shares |
110.16%
2.4665
|
-24.27 | 27.00 | 26.94 | -2.0708 |
| Basic Earnings Per Share |
86.36%
-1.11
|
-8.14 | -0.08 | -0.10 | -0.18 |
| Diluted Earnings Per Share |
86.36%
-1.11
|
-8.14 | -0.08 | -0.10 | -0.17 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):